Aurobindo Pharma gets USFDA final approval for Perampanel tablets
Aurobindo Pharma Limited announced it has received final approval from the U.S. Food & Drug Administration (USFDA) to manufacture and market Perampanel tablets in strengths of 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg.